Emergency department visits for antibiotic-associated adverse events.

BACKGROUND Drug-related adverse events are an under-appreciated consequence of antibiotic use, and the national magnitude and scope of these events have not been studied. Our objective was to estimate and compare the numbers and rates of emergency department (ED) visits for drug-related adverse events associated with systemic antibiotics in the United States by drug class, individual drug, and event type. METHODS We analyzed drug-related adverse events from the National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance project (2004-2006) and outpatient prescriptions from national sample surveys of ambulatory care practices, the National Ambulatory Medical Care Survey and the National Hospital Ambulatory Medical Care Survey (2004-2005). RESULTS On the basis of 6614 cases, an estimated 142,505 visits (95% confidence interval [CI], 116,506-168,504 visits) annually were made to US EDs for drug-related adverse events attributable to systemic antibiotics. Antibiotics were implicated in 19.3% of all ED visits for drug-related adverse events. Most ED visits for antibiotic-associated adverse events were for allergic reactions (78.7% of visits; 95% CI, 75.3%-82.1% of visits). One-half of the estimated ED visits were attributable to penicillins (36.9% of visits; 95% CI, 34.7%-39.2% of visits) and cephalosporins (12.2%; 95% CI, 10.9%-13.5%). Among commonly prescribed antibiotics, sulfonamides and clindamycin were associated with the highest rate of ED visits (18.9 ED visits per 10,000 outpatient prescription visits [95% CI, 13.1-24.7 ED visits per 10,000 outpatient prescription visits] and 18.5 ED visits per 10,000 outpatient prescription visits [95% CI, 12.1-25.0 ED visits per 10,000 outpatient prescription visits], respectively). Compared with all other antibiotic classes, sulfonamides were associated with a significantly higher rate of moderate-to-severe allergic reactions (4.3% [95% CI, 2.9%-5.8%] vs. 1.9 % [95% CI, 1.5%-2.3%]), and sulfonamides and fluoroquinolones were associated with a significantly higher rate of neurologic or psychiatric disturbances (1.4% [95% CI, 1.0%-1.7%] vs. 0.5% [95% CI, 0.4%-0.6%]). CONCLUSIONS Antibiotic-associated adverse events lead to many ED visits, and allergic reactions are the most common events. Minimizing unnecessary antibiotic use by even a small percentage could significantly reduce the immediate and direct risks of drug-related adverse events in individual patients.

[1]  J F Steiner,et al.  Antibiotic prescribing for children with colds, upper respiratory tract infections, and bronchitis. , 1998, JAMA.

[2]  J. Hickner A New Look at an Old Problem: Inappropriate Antibiotics for Acute Respiratory Infections , 2006, The Annals of Family Medicine.

[3]  S. Schappert,et al.  Medication therapy in ambulatory medical care: United States, 2003-04. , 2006, Vital and health statistics. Series 13, Data from the National Health Survey.

[4]  P. Gillman,et al.  Serotonin toxicity associated with the use of linezolid: a review of postmarketing data. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  Forum on Emerging Infections Antimicrobial Resistance: Issues and Options , 1998 .

[6]  Pentti Huovinen,et al.  Antimicrobial resistance , 1998, BMJ.

[7]  R. Pill,et al.  Understanding the culture of prescribing: qualitative study of general practitioners' and patients' perceptions of antibiotics for sore throats , 1998, BMJ.

[8]  D. Asch,et al.  Tensions in antibiotic prescribing , 2002, Journal of General Internal Medicine.

[9]  David W Bates,et al.  Antibiotic treatment of children with sore throat. , 2005, JAMA.

[10]  H. Merk,et al.  Fluoroquinolone-associated anaphylaxis in spontaneous adverse drug reaction reports in Germany: differences in reporting rates between individual fluoroquinolones and occurrence after first-ever use. , 2006, Drug safety.

[11]  D. Nash,et al.  Use of antibiotics for adult upper respiratory infections in outpatient settings: a national ambulatory network study. , 2006, Family medicine.

[12]  A. Ranaweera,et al.  Antimicrobial resistance , 1999 .

[13]  I. Arispe,et al.  Ambulatory care visits for treating adverse drug effects in the United States, 1995-2001. , 2005, Joint Commission journal on quality and patient safety.

[14]  David A Asch,et al.  Tensions in antibiotic prescribing: pitting social concerns against the interests of individual patients. , 2002, Journal of general internal medicine.

[15]  J. Powers Increasing the efficiency of clinical trials of antimicrobials: the scientific basis of substantial evidence of effectiveness of drugs. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  B. Lambert,et al.  Frequency estimates from prescription drug datasets (revision of #04‐11‐066A) , 2006, Pharmacoepidemiology and drug safety.

[17]  D. Pollock,et al.  National surveillance of emergency department visits for outpatient adverse drug events. , 2006, JAMA.

[18]  R. Leone,et al.  Adverse Drug Reactions Related to the Use of Fluoroquinolone Antimicrobials , 2003, Drug safety.

[19]  J. Hirschmann Antibiotics for common respiratory tract infections in adults. , 2002, Archives of internal medicine.

[20]  D. Malone,et al.  Excessive antibiotic use for acute respiratory infections in the United States. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  I. Cockburn,et al.  A statistical analysis of the magnitude and composition of drug promotion in the United States in 1998. , 2003, Clinical therapeutics.

[22]  C. Richards,et al.  Medication Use Leading to Emergency Department Visits for Adverse Drug Events in Older Adults , 2007, Annals of Internal Medicine.

[23]  Larry M Baddour,et al.  Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Card , 2007, Circulation.

[24]  D. Pollock,et al.  Evaluation and Overview of the National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance Project (NEISS-CADES) , 2007, Medical care.

[25]  Robert S. Dittus,et al.  Trends in antibiotic prescribing for adults in the United States—1995 to 2002 , 2005, Journal of General Internal Medicine.

[26]  Jonathan Sandoe,et al.  Guidelines for the prevention of endocarditis: report of the Working Party of the British Society for Antimicrobial Chemotherapy , 2006 .

[27]  William A Prescott,et al.  Incidence of carbapenem-associated allergic-type reactions among patients with versus patients without a reported penicillin allergy. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  Daniel E. Singer,et al.  Desire for antibiotics and antibiotic prescribing for adults with upper respiratory tract infections , 2003, Journal of General Internal Medicine.

[29]  Msph Dr. Ralph Gonzales MD,et al.  Public beliefs and use of antibiotics for acute respiratory illness , 2007, Journal of General Internal Medicine.

[30]  I. Gould A review of the role of antibiotic policies in the control of antibiotic resistance. , 1999, The Journal of antimicrobial chemotherapy.

[31]  J. Hughes,et al.  Preventing the emergence of antimicrobial resistance. A call for action by clinicians, public health officials, and patients. , 1997, JAMA.

[32]  N. Britten,et al.  Why do general practitioners prescribe antibiotics for sore throat? Grounded theory interview study , 2003, BMJ : British Medical Journal.

[33]  F. Wood,et al.  Socially responsible antibiotic choices in primary care: a qualitative study of GPs' decisions to prescribe broad-spectrum and fluroquinolone antibiotics. , 2007, Family practice.

[34]  M. Laouri,et al.  Analysis of Medication Use Patterns: Apparent Overuse of Antibiotics and Underuse of Prescription Drugs for Asthma, Depression, and CHF , 2003, Journal of managed care pharmacy : JMCP.

[35]  D. Pollock,et al.  National surveillance of emergency department visits for outpatient adverse drug events in children and adolescents. , 2008, The Journal of pediatrics.

[36]  M. Sharifzadeh,et al.  Anti‐infectives‐induced adverse drug reactions in hospitalized patients , 2005, Pharmacoepidemiology and drug safety.

[37]  D. Low,et al.  Strategies for stemming the tide of antimicrobial resistance. , 1998, JAMA.

[38]  Alexander Kopp,et al.  Outpatient gatifloxacin therapy and dysglycemia in older adults. , 2006, The New England journal of medicine.

[39]  A. Prochazka,et al.  Brief report: The risk of overanticoagulation with antibiotic use in outpatients on stable warfarin regimens , 2005, Journal of General Internal Medicine.